Chronic Phase Chronic Myeloid Leukemia

Chronic Phase Chronic Myeloid Leukemia is the indication for 6 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as: Leukemia, Myeloid, Chronic-Phase · Chronic Phase Chronic Myelogenous Leukemia · Myelogenous Leukemia, Chronic, Chronic Phase · Myeloid Leukemia, Chronic, Chronic-Phase · Leukemia, Myeloid, Chronic Phase
Classified under: Bone Marrow Diseases
Hematologic Neoplasms
Hemic and Lymphatic Disease, Unclassified
Indicated drugs: Asciminib
Bosutinib
Dasatinib
Daunorubicin
Nilotinib
Ponatinib

Resolves to

Vocabularies

MeSHM0023823ICD-10C92.1SNOMED CT1162588009MedDRA10024296UMLSC0023474

What you can answer from here — as of October 24, 2026

6Indicated drugsWith each drug's targets and mechanism

Listed above

12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

385Clinical trialsPhase, status and sponsor resolved per trial

4Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Chronic Phase Chronic Myeloid Leukemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.